TrialCancer medicine2016

Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021.

Cynthia Wetmore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.